Virtual manufacturing of medical devices

AI Summary

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has issued comprehensive guidance outlining the obligations for virtual manufacturers—entities that place medical devices on the market under their own name while outsourcing design and production to a third party. Under the UK Medical Devices Regulations 2002, these entities hold the primary legal responsibility for product compliance, regardless of their lack of physical manufacturing facilities. Key issues addressed in this guidance include the frequent failure of virtual manufacturers to maintain complete technical documentation and the absence of robust contractual agreements with their subcontractors. To ensure compliance, companies must secure a full copy of the technical file or establish a legally binding agreement that ensures immediate access to all necessary data during regulatory audits. Required actions for these organizations include the implementation of a rigorous quality management system, the establishment of clear dispute resolution protocols, and the active monitoring of post-market performance. Furthermore, virtual manufacturers must ensure that any changes in production arrangements or subcontractors are properly documented and communicated to the relevant regulatory bodies. This guidance emphasizes that the virtual manufacturer cannot delegate their ultimate accountability for the safety and performance of the device to the contract manufacturer.